Typical and atypical antipsychotic use and relapses in schizophrenia

被引：0
|
作者：
Cáceres, M. C.
Peñas-Lledó, E. M.
Dorado, P.
de la Rubia, A.
González, I.
Gutierrez, J. R.
LLerena, A.
机构：
[1] Univ Extremadura, Univ Hosp, Sch Med,Clin Res Ctr,CICAB, Fundesalud,Serv Extremeno Salud,Dept Pharmacol &, Badajoz, Spain
[2] Merida Psychiat Hosp, Merida, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2006年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：34 / 35
页数：2
相关论文
共 50 条
  • [41] Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia
    Duncan, GE
    Zorn, S
    Lieberman, JA
    MOLECULAR PSYCHIATRY, 1999, 4 (05) : 418 - 428
  • [42] RELATIONSHIPS BETWEEN SERUM TOTAL ANTIOXIDANT CAPACITY AND TYPICAL/ATYPICAL ANTIPSYCHOTIC TREATMENT IN ACUTE PARANOID SCHIZOPHRENIA
    Diaz-Mesa, E.
    Morera-Fumero, A.
    Abreu-Gonzalez, P.
    Henry-Benitez, M.
    Fernandez-Lopez, L.
    Yelmo-Cruz, S.
    Gracia-Marco, R.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [43] Quetiapine versus typical antipsychotic medications for schizophrenia
    Suttajit, Sirijit
    Srisurapanont, Manit
    Xia, Jun
    Suttajit, Siritree
    Maneeton, Benchalak
    Maneeton, Narong
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [44] Mechanisms of typical and atypical antipsychotic drug action in relation to dopamine and NMDA receptor hypofunction hypotheses of schizophrenia
    G E Duncan
    S Zorn
    J A Lieberman
    Molecular Psychiatry, 1999, 4 : 418 - 428
  • [45] Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change
    Soumerai, Stephen B.
    Zhang, Fang
    Ross-Degnan, Dennis
    Ball, Daniel E.
    LeCates, Robert F.
    Law, Michael R.
    Hughes, Tom E.
    Chapman, Daniel
    Adams, Alyce S.
    HEALTH AFFAIRS, 2008, 27 (03) : W185 - W195
  • [46] The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia
    Leslie, DL
    Rosenheck, R
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2001, 189 (06) : 377 - 383
  • [47] Atypical antipsychotic medication and substance use-related outcomes in the treatment of schizophrenia
    Petrakis, IL
    Leslie, D
    Finney, JW
    Rosenheck, R
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (01): : 44 - 49
  • [48] Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant
    Rohit Singh
    Sankha Shubhra Chakrabarti
    Upinder Kaur
    DARU Journal of Pharmaceutical Sciences, 2024, 32 : 439 - 441
  • [49] Atypical extrapyramidal manifestation of a typical antipsychotic with serotonergic antidepressant
    Singh, Rohit
    Chakrabarti, Sankha Shubhra
    Kaur, Upinder
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 32 (01) : 439 - 441
  • [50] Typical and atypical antipsychotic drugs: basic neurobiological aspects
    Svensson, TH
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 89 - 89
12345